SCHEMBL4926539

SCHEMBL4926539

CCC(C)Nc1cc(C)cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MCL1 Q07820 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.33
RAB9A P51151 2/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
THRB P10828 5/20 0.33
THRA P10827 4/20 0.33
NPC1 O15118 1/20 0.33
PAX8 Q06710 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
ATM Q13315 1/20 0.33
MMP1 P03956 1/20 0.32
EGLN1 Q9GZT9 1/20 0.31
TOP2A P11388 1/20 0.31
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932593 0.93 THRA (0.35) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL4935198 0.91 ALDH1A1 (0.38) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL4930888 0.91 GPR139 (0.37) MEN1KMT2AMCL1SMN1; SMN2RAB9A
SCHEMBL4927556 0.87 SMN1; SMN2 (0.39) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL5109654 0.87 THRA (0.38) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL4929941 0.87 SMN1; SMN2 (0.38) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL4931627 0.86 SMN1; SMN2 (0.36) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL5717861 0.86 THRA (0.36) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL5118797 0.85 SMN1; SMN2 (0.39) MEN1KMT2ASMN1; SMN2RAB9AMAPT
SCHEMBL4934028 0.85 SMN1; SMN2 (0.36) MEN1KMT2ASMN1; SMN2RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA MEN1 773/4885KMT2A 1742/4885MCL1 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.